Lookout for Price Target? Abbott Laboratories (ABT), Johnson & Johnson (JNJ)

Lloyd Doyle
September 23, 2017

Parsec Mngmt accumulated 249,054 shares or 0.96% of the stock. The institutional investor held 4.89 million shares of the major pharmaceuticals company at the end of 2017Q2, valued at $237.76M, down from 5.10 million at the end of the previous reported quarter. Abbott Laboratories now has $89.36B valuation. The stock declined 0.26% or $0.19 reaching $71.57 per share. Insiders have sold 218,150 shares of company stock valued at $10,811,179 over the last 90 days. About shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since September 22, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Analysts expect Atlantic Coast Financial Corp (NASDAQ:ACFC) to report $0.11 EPS on October, 25.They anticipate $0.03 EPS change or 37.50% from last quarter's $0.08 EPS. ACFC's profit would be $1.71 million giving it 19.70 P/E if the $0.11 EPS is correct. Mercer Cap Advisers reported 100 shares or 0.01% of all its holdings. The target implies a -5.13% decrease from where the shares are now trading. II (EOS) has risen 12.90% since September 22, 2016 and is uptrending. It has outperformed by 8.74% the S&P500.

Atlantic Coast Financial Corporation is a thrift holding company.

The company's consensus rating on Reuter's scale remained unchanged from 2.5 to 2.5 during a month. The Company, through its subsidiary, Atlantic Coast Bank, a federally chartered and insured stock savings bank supervised by the Office of the Comptroller of the Currency (the OCC), serves the Northeast Florida, Central Florida and Southeast Georgia markets. It has a 21.5 P/E ratio. The Bank provides residential and commercial loans to its general service area (Montgomery, Bucks and Philadelphia Counties of Pennsylvania).

Investors sentiment decreased to 0.92 in 2017 Q2. Its down 0.75, from 1.63 in 2017Q1. Vanguard Group Inc bought 20,036 shares as the company's stock declined 9.32% while stock markets rallied. 3 funds opened positions while 9 raised stakes. Ejf reported 0.73% of its portfolio in Atlantic Coast Financial Corp (NASDAQ:ACFC). Everence Cap invested in 0.61% or 51,251 shares. Loomis Sayles & Ltd Partnership, Massachusetts-based fund reported 1.06 million shares. Montgomery Mgmt owns 5,480 shares. Cullinan Associate Inc, Kentucky-based fund reported 279,623 shares. Perkins Coie Tru Com holds 0.05% or 1,772 shares in its portfolio. Mufg Americas holds 0% of its portfolio in Atlantic Coast Financial Corp (NASDAQ:ACFC) for 361 shares.


Since March 31, 2017, it had 0 buys, and 2 selling transactions for $60,722 activity. Contreras Jaime had sold 767 shares worth $34,240 on Friday, March 31.

Among 23 analysts covering Abbott Laboratories (NYSE:ABT), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Argus Research maintained Abbott Laboratories (NYSE:ABT) rating on Friday, July 21. Analysts have a mean recommendation of 2.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). The rating was maintained by Jefferies with "Buy" on Thursday, July 14. Jefferies maintained the stock with "Buy" rating in Thursday, July 14 report. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: Seekingalpha.com and their article: "Buy Abbott Laboratories - Cramer's Lightning Round (9/15/17)" published on September 18, 2017 as well as Beckershospitalreview.com's news article titled: "Alaska union-benefits fund sues Abbott over faulty St. Jude defibrillators" with publication date: September 21, 2017. The firm earned "Buy" rating on Thursday, June 29 by Jefferies. Finally, Wells Fargo & Company reissued an "outperform" rating and issued a $54.00 price target (up from $47.50) on shares of Abbott Laboratories in a report on Friday, June 30th. Cwm Limited stated it has 0.15% in Abbott Laboratories (NYSE:ABT). The firm has "Neutral" rating by UBS given on Tuesday, September 22. The firm earned "Buy" rating on Thursday, July 20 by Stifel Nicolaus. The stock of Abbott Laboratories (NYSE:ABT) has "Market Perform" rating given on Friday, January 29 by William Blair.

Investors sentiment is 1.1 in 2017 Q2. Its down 0.75, from 1.63 in 2017Q1. It turned negative, as 69 investors sold ABT shares while 545 reduced holdings. 35 funds opened positions while 68 raised stakes. Employees Retirement Association Of Colorado, a Colorado-based fund reported 758,712 shares. Atwood & Palmer Inc. now owns 3,270 shares of the healthcare product maker's stock valued at $145,000 after buying an additional 2,000 shares during the period. 5,080 were reported by Gould Asset Management Ltd Company Ca.

Abbott Laboratories (NYSE:ABT) traded up 0.72% during mid-day trading on Friday, hitting $51.80. Jpmorgan Chase Com owns 17.96 million shares. Loeb Prns stated it has 30,700 shares or 0.43% of all its holdings. Maple Inc reported 186,391 shares. The stock rose 0.59% or $0.11 reaching $18.91 per share. Cypress Asset Mgmt Incorporated Tx accumulated 39,993 shares. Next Gp reported 0% of its portfolio in Abbott Laboratories (NYSE:ABT). Cibc World Mkts Corp invested in 0.13% or 245,216 shares.

Advisors Asset Management Inc. holds 0.11% of its portfolio in Eaton Vance Enhanced Equity Incm. Fd. Invesco holds 0% of its portfolio in Esterline Technologies Corporation (NYSE:ESL) for 62,704 shares. Banque Pictet And Cie invested in 0.5% or 435,262 shares. Perkins Capital Management Inc. now owns 83,546 shares of the healthcare product maker's stock valued at $3,710,000 after acquiring an additional 55,471 shares during the last quarter. It also upped First Rep Bk San Francisco C (NYSE:FRC) stake by 84,282 shares and now owns 2.23M shares.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER